Elevated Blood Pressure Increases Pneumonia Risk: Epidemiological Association and Mendelian Randomization in the UK Biobank

[1]  B. Bozkurt,et al.  Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 , 2020, Journal of Cardiac Failure.

[2]  M. Caulfield,et al.  White Blood Cells and Blood Pressure , 2020, Circulation.

[3]  Yue-chun Shen,et al.  Associations between untraditional risk factors, pneumonia/lung cancer, and hospital fatality among hypertensive men in Guangzhou downtown , 2020, Scientific Reports.

[4]  Hongyu Zhao,et al.  Genetic Association of Finger Photoplethysmography-Derived Arterial Stiffness Index With Blood Pressure and Coronary Artery Disease. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[5]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[6]  Christian Gieger,et al.  Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits , 2018, Nature Genetics.

[7]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[8]  Dylan S. Small,et al.  Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score , 2018, The Annals of Statistics.

[9]  G. Davey Smith,et al.  Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.

[10]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[11]  P. Donnelly,et al.  Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.

[12]  D. Bennett,et al.  Mendelian randomisation in cardiovascular research: an introduction for clinicians , 2017, Heart.

[13]  G. Davey Smith,et al.  Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges , 2017, bioRxiv.

[14]  Olena O Yavorska,et al.  MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.

[15]  He Gao,et al.  Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk , 2017, Nature Genetics.

[16]  P. López-Jaramillo,et al.  A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension , 2016, The Lancet.

[17]  F. Dudbridge,et al.  Robust instrumental variable methods using multiple candidate instruments with application to Mendelian randomization , 2016, 1606.03729.

[18]  Jackson T. Wright,et al.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.

[19]  E. Hoffman,et al.  Quantitative Dual-Energy Computed Tomography Supports a Vascular Etiology of Smoking-induced Inflammatory Lung Disease. , 2016, American journal of respiratory and critical care medicine.

[20]  L. Wain,et al.  Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank , 2015, The Lancet. Respiratory medicine.

[21]  A. Agustí,et al.  Cardiovascular comorbidity in COPD: systematic literature review. , 2013, Chest.

[22]  D. Bluemke,et al.  Associations Among Lung Function, Arterial Elasticity, and Circulating Endothelial and Inflammation Markers: The Multiethnic Study of Atherosclerosis , 2013, Hypertension.

[23]  D. Caldeira,et al.  Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[24]  A. Waisman,et al.  Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2011, Circulation.

[25]  Tracey H. Taveira,et al.  Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III. , 2010, American journal of hypertension.

[26]  D. Harrison,et al.  Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction , 2007, The Journal of experimental medicine.

[27]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[28]  J. V. Sarma,et al.  Regulatory effects of iNOS on acute lung inflammatory responses in mice. , 2003, The American journal of pathology.

[29]  T. Ogihara,et al.  Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. , 1999, American journal of hypertension.

[30]  D. Black.  HEALTH AND DEPRIVATION: Inequality and the north , 1988 .

[31]  P. Townsend,et al.  Health and Deprivation: Inequality and the North , 1987 .